Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 20th Mar 2013 08:53

Abcam: Canaccord Genuity moves target price from 344p to 358p, but still recommends selling.Antofagasta: Jefferies cuts target price from 1350p to 1100p, while keeping a hold recommendation.ASOS: Cantor Fitzgerald raises target price from 2500p to 2900p reiterating a hold recommendation. Panmure Gordon increases target price from 3300p to 4000p and retains its buy recommendation. Canaccord Genuity ups target price from 2600p to 3400p and upgrades from hold to buy.AstraZeneca: Morgan Stanley increases target price from 3020p to 3310p and maintains an equal-weight rating.BHP Billiton: Jefferies lowers target price from 2600p to 2550p reiterating a buy recommendation.British Sky Broadcasting Group: Goldman Sachs moves target price from 1040p to 1070p keeping a strong buy recommendation.Cairn Energy: Deutsche Bank shifts target price from 335p to 340p and retains a buy recommendation.Centrica: Citigroup shifts target price from 360p to 370p, while downgrading to neutral.Chariot Oil & Gas: Cantor Fitzgerald upgrades from sell to hold with a target price of 21p. Investec lowers target price from 21p to 31p, while its hold recommendation remains unchanged.Charles Stanley: Canaccord Genuity takes target price from 370p to 403p upgrading to buy.Compass Group: Bank of America moves target price from 885p to 925p and retains a buy recommendation.Daily Mail & General Trust: Jefferies ups target price from 683p to 800p leaving its buy recommendation unchanged. Goldman Sachs raises target price from 590p to 695p, but downgrades to sell.Domino Printing Sciences: Citigroup moves target price from 579p to 610p, but downgrades to sell.EG Solutions: Panmure Gordon shifts target price from 88p to 92p and leaves its hold recommendation unchanged.Filtrona: Canaccord Genuity moves target price from 690p to 795p and maintains its buy recommendation.FlyBe: HSBC Holdings cuts target price from 70p to 50p and downgrades to neutral.Genus: Morgan Stanley increases target price from 1360p to 1740p, while staying with its overweight rating.Hammerson: Oriel Securities upgrades to add.Hochschild Mining: HSBC Holdings lowers target price from 500p to 460p maintaining an overweight rating.Howden Joinery Group: Jefferies raises target price from 160p to 200p and keeps a hold recommendation. UBS takes target price from 215p to 250p retaining a buy recommendation.Informa: Goldman Sachs moves target price from 555p to 600p and stays with its buy recommendation.InterContinental Hotels Group: Nomura ups target price from 1670p to 2066p, while its neutral rating remains unchanged.ITV: Goldman Sachs ups target price from 131p to 154p and maintains a buy recommendation.Kazakhmys: Jefferies reduces target price from 800p to 500p, while maintaining a hold recommendation.Lonmin: Societe Generale increases target price from 38p to 110p, but still recommends selling.National Grid: Credit Suisse takes target price form 770p to 800p and keeps an outperform rating.Optos: N+1 Singer downgrades to sell with a target price of 172p. Canaccord Genuity shifts target price from 313p to 312p keeping a buy recommendation.Reed Elsevier: Goldman Sachs raises target price from 734p to 800p, while leaving its neutral rating unchanged.Rentokil: RBC shifts target price from 105p to 115p reiterating an outperform rating.Rio Tinto: Jefferies cuts target price from 4300p to 4100p, while maintaining a buy recommendation.Royal Bank of Scotland: Liberum Capital upgrades to buy with its target price at 340p.Sainsbury: Deutsche Bank moves target price from 309p to 327p and reiterates a hold recommendation.Salamander Energy: Deutsche Bank revises target price from 280p to 310p maintaining its buy recommendation.Smiths Group: Investec places its target price (prev.: 1430p) under review and keeps its buy recommendation.Synthomer: Deutsche Bank ups target price from 175p to 200p and leaves its hold recommendation unaltered.Tanfield Group: WH Ireland restarts coverage with a speculative buy, while keeping its target price still under review.UNITE Group: Espirito Santo revises target price from 319p to 371p and reiterates a buy recommendation.Vatukoula Gold Mines: WH Ireland reduces target price from 115p to 80p, while maintaining its buy recommendation.William Hill: Panmure Gordon ups target price from 436p to 475p and stays with its buy recommendation.Wolseley: Liberum Capital raises target price from 3150p to 3730p and upgrades to buy.WPP Group: Goldman Sachs ups target price from 1155p to 1340p keeping a buy recommendation.
More News
31 Jul 2018 15:42

Berenberg changes mind on Abcam, reinstating 'buy' rating

(Sharecast News) - Analysts at Berenberg on Tuesday upgraded their rating for shares of Abcam from 'Hold' to 'Buy' after having downgraded shares of the antibodies supplier just three months ago.

Read more
31 Jul 2018 13:26

Tuesday broker round-up

(Sharecast News) - Abcam: Berenberg upgrades to buy with a target price of 1,640p.

Read more
18 Jun 2018 16:22

Abcam Appoints Former Celltech CFO As Non-Executive Chairman

LONDON (Alliance News) - Life sciences company Abcam PLC said Monday it has appointed the former chief financial officer of Celtech Group PLC as a non-executive chairman.Peter Allen is a at

Read more
9 May 2018 16:16

UPDATE: Horizon Discovery Outlook Strong In Face Of Abcam Pull-Out

LONDON (Alliance News) - Horizon Discovery Group PLC on Wednesday noted Abcam PLC's statement earlier in the day it will not be making an offer for Horizon.The gene modulation company a

Read more
9 May 2018 12:33

Abcam Decides Not To Make An Offer For Horizon Discovery Group

LONDON (Alliance News) - Abcam PLC on Wednesday said it has ended plans to make an offer for Horizon Discovery Group PLC following the latter's release of its annual results and a management a

Read more
2 May 2018 18:25

Horizon Discovery Confirms Rejected "Unsolicited" Abcam Proposal

LONDON (Alliance News) - Genomics firm Horizon Discovery Group PLC on Wednesday confirmed it had rejected an unsolicited and "highly conditional" proposal from Abcam PLC.The life

Read more
2 May 2018 16:41

Horizon Discovery Rejects GBP270.0 Million Proposal From Abcam

LONDON (Alliance News) - Abcam PLC on Wednesday said gene editing company Horizon Discovery Group PLC has rejected its acquisition proposal.The life science e-commerce company said it a for

Read more
15 Mar 2018 09:53

BROKER RATINGS SUMMARY: Barclays Reviews Banks, Goldman Property Firms

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:----------FTSE WITH

Read more
7 Mar 2018 15:23

FDA head Gottlieb criticizes industry for "Kabuki drug-pricing"

WASHINGTON, March 7 (Reuters) - U.S. Food and Drug Administrator Scott Gottlieb on Wednesday criticized drugmakers, pharmacy benefit managers and health a

Read more
11 Jan 2017 09:36

BROKER RATINGS SUMMARY: Morgan Stanley Upgrades BT To Overweight

Read more
10 Jan 2017 10:30

Abcam's revenue to be ahead of expectations

(ShareCast News) - Cambridge-based life science company Abcam said it anticipates revenue will continue to grow in the second half of the year, ahead of expectations. The AIM-listed company company expects revenue to grow 10% on a constant currency basis and 30% on a reported basis as it is on track

Read more
24 Oct 2016 10:28

Abcam commits to massive new Cambridge headquarters

(ShareCast News) - Life science research tools supplier Abcam announced on Monday that it has committed to the lease of a new facility for its global headquarters at the Biomedical Campus in Cambridge, subject to the grant of full planning approval. The AIM-traded firm said the purpose-built facilit

Read more
28 Sep 2016 11:29

DIRECTOR DEALINGS: Abcam COO Donates 62,000 Shares to Charity

Read more
12 Sep 2016 10:40

Abcam earnings dip slightly in year of investment

(ShareCast News) - Life science research tool supplier Abcam announced its preliminary results for the year to 30 June on Monday, with catalogue revenue increasing by 17.4% on a reported basis to £159.0m. The AIM-traded firm said at constant exchange rates the increase was 14.4%. Total revenue incr

Read more
2 Sep 2016 10:21

Abcam to place shares on AIM to pay vendors following acquisition

(ShareCast News) - Life science company Abcam is to pay the first performance-based payment of $5.2m for its acquisition of AmioMx through a share placing on AIM, the London Stock Exchange's junior market. The Cambridge-based company bought AmioMx in November 2015 which included an agreement to make

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.